Open AccessThe Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
Author(s) -
Panagiotis Theofilis,
Aikaterini Vordoni,
Rigas Kalaitzidis
Publication year - 2022
Publication title -
american journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 85
eISSN - 1421-9670
pISSN - 0250-8095
DOI - 10.1159/000525441
Subject(s) - melatonin , medicine , endocrinology , insulin resistance , kidney disease , type 2 diabetes , diabetes mellitus , pathophysiology of hypertension , pineal gland , blood pressure
The increasing incidence of chronic kidney disease (CKD), as a consequence of the high prevalence of arterial hypertension and type 2 diabetes mellitus (T2DM), warrants the need for developing effective treatment approaches. In this regard, the pineal gland-derived hormone melatonin may represent an appealing treatment approach of CKD and its associated risk factors.